ArticleThe Journal of experimental medicine2021

Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1.

Paul Bastard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.